瀏覽量: 129
- 產(chǎn)品名稱: Research Grade Ocrelizumab ( 奧瑞組單抗 )
- 產(chǎn)品貨號: CSD00139
- 貨期: 現(xiàn)貨
- 價格與訂購: 2480
- 數(shù)量:
- 規(guī)格: 100μg
- 產(chǎn)品信息
- 如何訂購
貨號(Catalog No.)
CSD00139
通用名INN
Ocrelizumab
純度(Purity
>95%
濃度( Concentration)
1mg/ml
Formulation
PBS buffer PH7.5
Source
CHO cells
內(nèi)毒素(Endotoxin level)
Please contact with the lab for this information.
產(chǎn)品描述(Description)
Ocrelizumab is a CD20-directed cytolytic antibody indicated for the treatment of patients with relapsing or primary progressive forms of multiple sclerosis. It is a second-generation recombinant humanized monoclonal IgG1 antibody that selectively targets the B lymphocytes that express the CD20 antigen. As a humanized molecule, ocrelizumab is expected to be less immunogenic with repeated infusions which improves the benefit-to-risk profile for patients with relapsing or progressive forms of MS.
別名(Alternative names)
2H7
靶點;物種(Specificity target name;species)
MS4A1/CD20[Homo sapiens]
種類(Species)
Humanized
受體鑒定(Receptor identification)
IgG1-nd
分子量(MV)
145000.00 Da
CAS
637334-45-3
存儲條件(Storage)
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
Store at +4°C short term (1-2 weeks).
Store at -20 °C 12 months.
Store at -80°C long term.
Note
For research use only .